Letter to the editor: Treatment failure of low molecular weight heparin in diabetic patient

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages

  Tulino, D ^a   Imbalzano, E ^b   Casale, M ^b   D'Angelo, M ^b   Coglitore, S ^b   Di Bella, G ^b   Dattilo, G ^b  

^a Hospital G Jazzolino Vibo Valentia   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Immobilization Syndrome; Low molecular weight heparin; Pulmonary embolism; Thrombosis prevention

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

AGED; CASE REPORT; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; HUMAN; IMMOBILIZATION SYNDROME; LETTER; LUNG EMBOLISM; THROMBOSIS PREVENTION; TREATMENT FAILURE;

IMMOBILIZATION SYNDROME; LOW MOLECULAR WEIGHT HEPARIN; PULMONARY EMBOLISM; THROMBOSIS PREVENTION;

AGED; DIABETES MELLITUS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; TREATMENT FAILURE;

EID: 84885296839     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.064     Document Type: Article

References (33)

1. Hendriks JM, Crijns HJ, Tieleman RG, Vrijhoef HJ. The atrial fibrillation knowledge scale: Development, validation and results. Int J Cardiol Jan 8 2013;168(2):1422-8.
2. Merli GJ. PathoPhysiology of venous thrombosis and the diagnosis of deep vein thrombosis-pulmonary embolism In the elderly. Cardiol Clin May 2008;26(2): 203-19 [vi., Review].
3. Chao TF, Liu CJ, Chen SJ, et al. CHADS(2) score and risk of new-onset atrial fibrillation: a nationwide cohort study In Taiwan. Int J Cardiol 2013;168(2): 1360-3.
4. Hoffmann R. The thrombo-embolic risk In surgery. Hepatogastroenterology Aug 1991;38(4):272-8 [Review].
5. Patanè S, Marte F, Sturiale M, Dattilo G. Changing axis deviation and acute myocardial Infarction. Int J Cardiol Aug 18 2011;151(1):e1-3.
6. Yoshino S, Yoshikawa A, Hamasaki S, et al. Atrial fibrillation-induced endothelial dysfunction Improves after restoration of sinus rhythm. Int J Cardiol 2013;168(2): 1280-5.
7. Patanè S, Marte F, Dattilo G, Sturiale M. Acute myocardial Infarction and left bundle branch block with changing axis deviation. Int J Cardiol Feb 9 2012;154(3): e47-9.
8. Patanè S, Marte F, Sturiale M, Dattilo G, Luzza F. Atrial flutter, ventricular tachycardia and changing axis deviation associated with scleroderma. Int J Cardiol Dec 1 2011;153(2):e25-8.
9. Salam AM, Albinali HA, Al-Mulla AW, et al. Women hospitalized with atrial fibrillation: Gender differences, trends and outcome froma 20-year registry In a middle eastern country (1991-2010). Int J Cardiol 2013;168(2):975-80.
10. Casado-Arroyo R, Chierchia GB, Rodriguez-Mañero M, et al. Atrial fibrillation outcomes: changing the paradigm. Int J Cardiol Jun 20 2013;166(2):545-7.
11. Patanè S, Marte F, Dattilo G, Sturiale M. Changing axis deviation during atrial fibrillation. Int J Cardiol Jan 12 2012;154(1):e1-3.
12. Wu J, Wang J, Jiang S, et al. The efficacy and safety of low Intensity warfarin therapy In Chinese elderly atrial fibrillation patients with high CHADS(2) risk score. Int J Cardiol Nov 28 2012. http://dx.doi.org/10.1016/j. ijcard.2012.11.078.
13. Chao TF, Liu CJ, Chen SJ, et al. The Association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: a nationwide case-control study. Int J Cardiol Oct 6 2012. http://dx.doi.org/10.1016/j. ijcard.2012.09.058.
14. Dattilo G, Lamari A, Crosca S, et al. Correlation between Insulin resistance and endothelial dysfunction assessed by flow-mediated dilation. Recenti Prog Med Sep 2012;103(9):328-32.
15. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace Oct 2012;14(10):1385-413.
16. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J Nov 2012;33(21):2719-47.
17. Dattilo G, Lamari A, Messina F, et al. The chance finding at multislice computed tomography coronary angiography of an ectopic origin of the left circumflex coronary artery from the right sinus of Valsalva. Int J Cardiol Jun 2 2011;149(2):e43-6.
18. Dattilo G, Tulino V, Tulino D, Lamari A,Marte F, Patanè S. Interatrial defect, ventricular septal defect and patent ductus arteriosus In a 2-day-old newborn Infant. Int J Cardiol May 15 2009;134(2):e82-3.
19. Guo Y, Pisters R, Apostolakis S, et al. Stroke risk and suboptimal thromboprophylaxis In Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an Impact? Int J Cardiol Oct 23 2012. http://dx.doi.org/10.1016/j.ijcard.2012.09.187.
20. Zannad F, Stough WG, Regnault V, et al. Is thrombosis a contributor to heart failure pathoPhysiology? Possible mechanisms, therapeutic opportunities, and clinical Investigation challenges. Int J Cardiol Jan 5 2013. http://dx.doi.org/10.1016/j.ijcard.2012.12.018.
21. Gooshah Gir AA, Namdar H, Emaratkar E, et al. Avicenna's view on the prevention of thrombosis. Int J Cardiol Jun 5 2013;166(1):274-5.
22. Task Force for Preoperative Cardiac Risk Assessment, Perioperative Cardiac Management In Non-cardiac Surgery, European Society of Cardiology (ESC), Poldermans D, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management In non-cardiac surgery. Eur Heart J Nov 2009;30(22):2769-812.
23. Barbarash LS, Sumin AN, Barbarash OL, Ivanov SV. Pre-operative cardiac risk assessment and perioperative cardiac management In non-cardiac surgery. Kardiologiia 2012;52(5):77-87 [Review].
24. Soo Hoo GW. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med Apr 2013;7(2):171-91.
25. Abad Rico Ji, Llau Pitarch JV, Rocha E. Overviewof venous thromboembolism.Drugs Dec 14 2010;70(Suppl. 2):3-10.
26. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management In non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management In Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol Feb 2010;27(2):92-137.
27. Dattilo G, Tulino D, Lamari A, Tulino V, Marte F, Patanè S. Treatment failure of low molecular weight heparin In a patient with an aortic mechanical prosthesis. Int J Cardiol Jan 21 2011;146(2):e30-2.
28. Dattilo G, Lamari A, Di Bella G, et al. Treatment failure of low molecular weight heparin bridging therapy. Int J Cardiol Apr 30 2013. http://dx.doi.org/10.1016/j.ijcard.2013.03.183.
29. Buchholz S, Robaei D, Jacobs NH, O'Rourke M, Feneley MP. Thromboembolic stroke with concurrent left atrial appendage and left atrial septal pouch thrombus. Int J Cardiol Dec 15 2012;162(1):e16-7.
30. Patanè S, Marte F, Risica G, et al. Treatment failure of low molecular weight heparin bridging therapy before a cardiac surgery Intervention In a patient with atrial fibrillation. Int J Cardiol Nov 12 2009;137(3):e59-60.
31. Zhang DY, Lozier J, Chang R, et al. Case study and review: treatment of tricuspid prosthetic valve thrombosis. Int J Cardiol Dec 15 2012;162(1):14-9.
32. Dattilo G, Lamari A, Tulino V, Scarano M, De Luca E, Mutone D, Busacca P. Congenital valvular heart disease with high familial penetrance. Recenti Prog Med Dec 2012;103(12):581-3.
33. Yu Hi, SheuWH, Lai CJ, Lee WJ, Chen YT. Endothelial dysfunction In type 2 diabetes mellitus subjects with peripheral artery disease. Int J Cardiol Mar 2001;78(1):19-25.